Summary
A 27-year-old woman is described whose disorder meets the DSM-III-R criteria for a diagnosis of schizophrenia and who was found to have a significantly increased serum level of homocysteine. Repeatedly, she improved on frequent cobalamin injections and deteriorated in periods without treatment. The effects of prolonged weekly treatment appeared to diminish as time went on, suggesting that the abnormality was not wholly cobalamin-dependent. It was found that methylenetetrahydrofolate reductase (MR) activity in cultured skin fibroblasts was reduced to a magnitude that is found among people with heterozygous deficiency. A defect in MR activity indicates a deficiency in methyltetrahydrofolate (MTHF), with a consequent reduction of the remethylation of homocysteine to methionine. Thus, reduced methylation may explain the increased levels of homocysteine and the transient effects of cobalamin treatment in the patient. Theoretically, MTHF should be the optimal treatment for her. The case reported highlights the importance of assessing the serum homocysteine level in order to detect methylation deficiency in patients with schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andreoli VM, Maffei T (1975) Blood levels of S-adenosylmethionine in schizophrenia. Lancet ii: 922
Berger PA, Elliott GR, Erdelyi E, Watson SJ, Wyatt RJ, Barchas JD (1977) Platelet methylene reductase activity in schizophrenia. Arch Gen Psychiatry 34: 808–809
Berlow S, Bachman RP, Berry GT, Donnell GN, Grix A, Levitsky LL, Hoganson G, Levy HL (1989) Betaine therapy in homocysteinemia. Brain Dysfunct 2: 10–24
Bracken P, Coll P (1985) Homocystinuria and schizophrenia. Literature review and case report. J Nerv Ment Dis 173: 51–55
Carl GF, Crews EL, Carmichael SM, Benesh FC, Smythies JR (1978) Four enzymes of one-carbon metabolism in blood cells of schizophrenics. Biol Psychiatry 13: 773–776
Cooper BA, Rosenblatt DS (1987) Inherited defects of vitamin B12 metabolism. Ann Rev Nutr 7: 291–320
Fekkes D, Pepplinkhuizen L, Bruinvels J (1991) Changes in serine metabolism by a serum factor present in a group of episodic psychotic patients. Biol Psychiatry 30: 966–972
Freeman JM, Finkelstein JD, Mudd SH (1975) Folate-responsive homocystinuria and “schizophrenia”. N Engl J Med 292: 491–496
Godfrey PSA, Toone BK, Carney MWP, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH (1990) Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336: 392–395
Haworth JC, Dilling LA, Surtees RAH, Seargeant LE, Lue-Shing H, Cooper BA, Rosenblatt DS (1993) Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet 45: 572–576
Holme E, Kjellman B, Ronge E (1989) Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child 64: 1061–1064
Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43: 414–421
Kang SS, Wong PW, Bock HGO, Horwitz A, Grix A (1991) Intermediate hyperhomo-cysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 48: 546–551
Levi RN, Waxman S (1975) Schizophrenia, epilepsy, cancer, methionine and folate metabolism. Pathogenesis of schizophrenia. Lancet ii: 11–13
Marcell PD, Stabler SP, Podell ER, Allen RH (1985) Quantitation of methylmalonic acid and other dicarboxylic acids in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 150: 58–66
McKeever MP, Weir DG, Molloy A, Scott JM (1991) Betaine-homocysteine methyltransferase: organ distribution in man, pig, and rat and subcellular distribution in the rat. Clin Sci 81: 551–556
Morere DA, Alarcon RD, Monti JA, Walter-Ryan WG, Bancroft AJ, Smythies JR, Tolbert LC (1986) Medication effects on one-carbon metabolism in schizophrenia, mania, and major depression. J Clin Psychopharmacol 6: 155–161
Mudd SH, Freeman JM (1974) N5,10-methylenetetrahydrofolate reductase deficiency and schizophrenia: a working hypothesis. J Psychiat Res 11: 259–262
Mudd SH, Uhlendorf BW, Freeman JM, Finkelstein JD, Shih VE (1972) Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem Biophys Res Commun 46: 905–912
Olney JW (1993) Role of excitotoxins in developmental neuropathology. APMIS [Suppl 40] 101: 103–112
Rasmussen K (1989) Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 35: 260–264
Rosenblatt DS, Lue-Shing H, Arzoumanian A, Low-Nang L, Matiaszuk N (1992) Methylenetetrahydrofolate reductase (MR) deficiency: thermolability of residual MR activity, methionine synthase activity, and methylcobalamin levels in cultured fibroblasts. Biochem Med Metabol Biol 47: 221–225
Smythies JR (1984) The transmethylation hypotheses of schizophrenia re-evaluated. Trends Neurosci: 45–47
Smythies JR, Alarcon RD, Morere D, Monti JA, Steele M, Tolbert LC, Walter-Ryan WG (1986) Abnormalities of one-carbon metabolism in psychiatric disorders: study of methionine adenosyltransferase kinetics and lipid composition of erythrocyte membranes. Biol Psychiatry 21: 1391–1398
Spiro HR, Schimke RN, Welch JP (1965) Schizophrenia in a patient with a defect in methionine metabolism. J Nerv Ment Dis 141: 285–290
Stabler SP, Marcell PD, Podell ER, Allen RH (1987) Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 162: 185–196
Turpini R, Albergati M, Gili C (1987) Macrocytosis in chronic alcoholism: a tentative correction with vitamin B 12, 5-methyltetrahydrofolate, and S-adenosylmethionine. Curr Ther Res 41: 38–46
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Regland, B., Johansson, B.V. & Gottfries, C.G. Homocysteinemia and schizophrenia as a case of methylation deficiency. J. Neural Transmission 98, 143–152 (1994). https://doi.org/10.1007/BF01277017
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01277017